At Amgen, our health equity efforts are focused on expanding access to clinical trial participation among historically underserved populations, facilitating comprehensive health education, and engaging with community support systems.
Amgen is working to advance policies and practices in support of achieving health equity so that more people have an opportunity to improve their health outcomes.
Amgen’s Representation in Clinical Research team, also known as RISE, is an Amgen program dedicated to improving the diversity and representation of participants in the Company's clinical trials.
Amgen’s Health Equity Challenge is working to identify scalable solutions to address core challenges to improving patient outcomes.
